A0520 - 89zirconium-labelled girentuximab (89zr-tlx250) pet in urothelial cancer patients (zipup) – a phase i trial of a novel staging modality for urothelial carcinoma.

Autor: Hayne, D. (AUTHOR), Gauci, R. (AUTHOR), Hawks, C. (AUTHOR), Al-Zubaidi, M. (AUTHOR), Viswambaram, P. (AUTHOR), Mccombie, S. (AUTHOR), Liow, E.C.H. (AUTHOR), Lenzo, N. (AUTHOR), Ferguson, T. (AUTHOR), Martina, S. (AUTHOR), Hayward, C. (AUTHOR), Redfern, A. (AUTHOR)
Zdroj: European Urology. Feb2023:Supplement 1, Vol. 83, pS744-S745. 2p.
Databáze: Academic Search Ultimate
Externí odkaz: